SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-024176
Filing Date
2019-04-09
Accepted
2019-04-09 19:00:38
Documents
1
Period of Report
2019-04-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12943
  Complete submission text file 0001209191-19-024176.txt   14334
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Issuer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O AKCEA THERAPEUTICS 55 CAMBRIDGE PARKWAY, STE 100 CAMBRIDGE MA 02142
Business Address
Goldberg Jeff Marc (Reporting) CIK: 0001703061 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38137 | Film No.: 19740373